デフォルト表紙
市場調査レポート
商品コード
1427874

大容量非経口薬(LVP)の世界市場レポート 2024年

Large Volume Parenteral (LVP) Global Market Report 2024

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.49円
大容量非経口薬(LVP)の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

大容量非経口薬(LVP)の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には8.7%の年間複合成長率(CAGR)で173億5,000万米ドルに成長すると予想されます。予測期間に予想される成長は、生物製剤とバイオシミラーの需要の増加、医療の増加、医薬品のアウトソーシングの拡大、個別化医療への注目の高まり、医薬品サプライチェーンのグローバリゼーションによるものと考えられます。予測期間中に予想される主要動向には、製造プロセスの技術進歩、医薬品生産における先進技術の統合、シングルユース技術の採用、高濃度製剤の開発、医薬品における3Dプリンティングの応用の増加などが含まれます。

大量非経口薬市場の予想される成長は、慢性疾患の有病率の増加によって促進されると予想されます。 3か月以上続き、時間の経過とともに悪化する可能性がある慢性疾患は、主に喫煙、煙への曝露、栄養不足などの要因によって増加しています。慢性疾患を持つ患者は、体力の維持をサポートするためにバランスの取れた比率の必須栄養素を必要とすることがよくあります。非経口投与方式は、消化器系を迂回して循環に直接吸収できるため、正確な薬剤投与量を送達するのに有利です。たとえば、2023年 1月、国立バイオテクノロジー情報センター(NCBI)は、米国で少なくとも1つの慢性疾患を患う50歳以上の個人が2050年までに99.5%増加し、2020年の7,152万2,000人から1億4,266万人に増加すると予測しました。したがって、慢性疾患の有病率の増加は、大量非経口薬市場の拡大の主要な推進力となっています。

大容量非経口薬市場で予想される成長は、医療支出の増加によってさらに促進されます。医療サービスや関連活動への財政投資の増加を反映する医療支出は、多くの場合、医療インフラの開発と拡大に関連しています。これには、新しい病院、クリニック、医療施設の設立が含まれ、医療サービスを提供する全体的な能力を強化し、大容量非経口薬(LVP)ソリューションの需要に貢献します。 2023年5月、国家統計局は、英国が2021年に医療に総額2,807億ポンドを支出し、これは1人当たり4,188ポンドに相当すると報告しました。特に、2020年から2021年にかけて医療支出は名目で9.4%、実質で9.7%増加しました。2021年には政府資金による医療支出が全医療支出の83.0%を占め、実質成長率は9.6%で2,331億ポンドに達しました。したがって、医療の高騰が、大量非経口薬市場の成長を促進する重要な要因として浮上しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の大容量非経口薬(LVP)市場の促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の大容量非経口薬(LVP)市場規模実績と成長、2018~2023年
  • 世界の大容量非経口薬(LVP)市場規模と成長予測、2023~2028年、2033年

第6章 市場セグメンテーション

  • 世界の大容量非経口薬(LVP)市場、タイプ別セグメンテーション、実績と予測、2018~2023年、2023~2028年、2033年
  • ソフトバッグLVP
  • プラスチックバッグLVP
  • ガラスボトルLVP
  • 世界の大容量非経口薬(LVP)市場、容量別セグメンテーション、実績と予測、2018~2023年、2023~2028年、2033年
  • 100~250ML
  • 250~500ML
  • 500~1,000ML
  • 1,000~2,000ML
  • 2,000ML
  • その他
  • 世界の大容量非経口薬(LVP)市場、用途別セグメンテーション、実績と予測、2018~2023年、2023~2028年、2033年
  • 基礎輸液
  • 治療用輸液
  • 栄養輸液
  • 世界の大容量非経口薬(LVP)市場、エンドユーザー別セグメンテーション、実績と予測、2018~2023年、2023~2028年、2033年
  • 病院
  • 医療センター
  • その他

第7章 地域と国の分析

  • 世界の大容量非経口薬(LVP)市場、地域別、実績と予測、2018~2023年、2023~2028年、2033年
  • 世界の大容量非経口薬(LVP)市場、国別、実績と予測、2018~2023年、2023~2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 大容量非経口薬(LVP)市場の競合情勢
  • 大容量非経口薬(LVP)市場の企業プロファイル
    • Pfizer Inc.
    • Fresenius Kabi AG
    • Abbott Laboratories Inc.
    • Becton Dickinson and Company
    • Otsuka Holdings Co Ltd.

第31章 その他の大手と革新的な企業

  • Baxter International Inc.
  • B Braun Melsungen AG
  • Grifols SA
  • Cipla Limited
  • ICU Medical Inc.
  • Biocon Limited
  • Sichuan Kelun Pharmaceutical Co. Ltd.
  • Alembic Pharmaceuticals Limited
  • Cadila Healthcare Ltd.
  • Gland Pharma Limited
  • Akums Drugs &Pharmaceuticals Ltd.
  • Beximco Pharmaceutical Ltd.
  • Nelson Laboratories LLC
  • Taj Pharmaceuticals Limited
  • Albert David Ltd.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在性分析

第36章 付録

目次
Product Code: r13718

Large Volume Parenteral (LVP) pertains to sterile intravenous solutions with a volume of 100 ml or more, undergoing terminal sterilization through heat. These solutions play a crucial role in intravenous infusions, facilitating the administration of hydration, nourishment, and medications.

The primary types of Large Volume Parenteral (LVP) include soft bag LVP, plastic bag LVP, and glass bottle LVP. Soft bag LVP involves the use of flexible bags containing sterilized intravenous solutions, employed in medical settings to deliver fluids and medications to patients. The varying volumes, ranging from 100 ml to 2000 ml and beyond, cater to different infusion needs, such as basic infusion, therapeutic infusion, and nutritious infusion. End-users of LVP include hospitals, medical centers, and other healthcare facilities.

The large volume parenteral (LVP) market research report is one of a series of new reports from The Business Research Company that provides large volume parenteral (LVP) market statistics, including large volume parenteral (LVP) industry global market size, regional shares, competitors with a large volume parenteral (LVP) market share, detailed large volume parenteral (LVP) market segments, market trends and opportunities, and any further data you may need to thrive in the large volume parenteral (LVP) industry. This large volume parenteral (LVP) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The large volume parenteral (lvp) market size has grown strongly in recent years. It will grow from $11.42 billion in 2023 to $12.44 billion in 2024 at a compound annual growth rate (CAGR) of 9.0%. The growth observed in the historic period can be ascribed to several factors, including the escalating prevalence of chronic diseases, a notable increase in the aging population, a growing demand for sterile pharmaceuticals, the expansion of healthcare infrastructure, and the establishment of regulatory frameworks for the pharmaceutical sector.

The large volume parenteral (lvp) market size is expected to see strong growth in the next few years. It will grow to $17.35 billion in 2028 at a compound annual growth rate (CAGR) of 8.7%. The anticipated growth in the forecast period can be credited to the increasing demand for biologics and biosimilars, a rise in healthcare expenditure, the expansion of pharmaceutical outsourcing, a heightened focus on personalized medicine, and the globalization of pharmaceutical supply chains. Key trends expected in the forecast period encompass technological advancements in manufacturing processes, the integration of advanced technologies in pharmaceutical production, the adoption of single-use technologies, the development of high-concentration formulations, and the increasing application of 3D printing in pharmaceuticals.

The projected growth in the large-volume parenteral market is expected to be fueled by the increasing prevalence of chronic diseases. Chronic diseases, characterized by lasting three months or longer and having the potential to worsen over time, are on the rise, driven primarily by factors such as tobacco use, exposure to smoke, and poor nutrition. Patients with chronic diseases often require a balanced ratio of essential nutrients to support strength maintenance. The parenteral mode of administration is advantageous in delivering precise pharmaceutical dosages, as it allows for direct absorption into the circulation, bypassing the digestive system. For example, in January 2023, the National Center for Biotechnology Information (NCBI) projected a 99.5% increase in individuals aged 50 years and older with at least one chronic illness in the US by 2050, rising from 71.522 million in 2020 to 142.66 million. Consequently, the growing prevalence of chronic diseases is a key driver for the expansion of the large-volume parenteral market.

The anticipated growth in the large-volume parenteral market is further driven by increasing healthcare expenditure. Healthcare expenditure, reflecting the rising financial investment in healthcare services and related activities, is often linked to the development and expansion of healthcare infrastructure. This includes the establishment of new hospitals, clinics, and healthcare facilities, enhancing the overall capacity to deliver medical services and contributing to the demand for Large Volume Parenteral (LVP) solutions. In May 2023, the Office for National Statistics reported that the UK spent a total of £280.7 billion on healthcare in 2021, amounting to £4,188 per person. Notably, healthcare spending increased by 9.4% in nominal terms and 9.7% in actual terms between 2020 and 2021. Government-financed healthcare expenditures accounted for 83.0% of all healthcare spending in 2021, reaching £233.1 billion with a real growth rate of 9.6%. Therefore, the escalating healthcare expenditure emerges as a significant factor driving the growth of the large-volume parenteral market.

Product innovation is a prominent and popular trend in the large-volume parenteral market, with major players dedicating efforts to the creation of innovative products to enhance their market positions. An illustrative example of this trend is observed with SGD Pharma SA, a France-based producer of molded and tubular glass for pharmaceutical primary packaging. In March 2022, SGD Pharma launched 100-ml type I molded glass vials that are sterile and ready for aseptic filling and finishing of parenteral medicinal formulations. These vials serve to prevent scratches, facilitate the visual examination of filled vials, and reduce the likelihood of rejection during quality control processes. This product innovation aligns with the market's focus on enhancing the quality and efficiency of large-volume parenteral products.

Major players in the market are strategically focusing on the development of innovative formulations to bolster their market position. The creation of innovative formulations plays a pivotal role in driving the success and growth of the large volume parenteral market. These formulations address clinical challenges, enhance patient outcomes, and adapt to the dynamic landscape of healthcare. For instance, in November 2022, WuXi AppTec, a leading pharmaceutical development and manufacturing company based in China, launched a Parenteral Formulation Manufacturing Line in Wuxi City. This new line features an integrated 15 m³ lyophilizer housed in a completely enclosed isolator, along with a fully automated vial loading and unloading system. The filling line accommodates vials for solutions and lyophilized powder in various sizes, enabling quick mode transitions and significantly accelerating large-volume parenteral drug product production speed at 200 vials per minute. The facility boasts an innovative filling machine and a state-of-the-art containment system, aligning with global cGMP requirements.

In March 2022, Fresenius Kabi, a healthcare company based in Germany, made a strategic move by acquiring Ivenix Inc. for $240 million. This acquisition aims to broaden Fresenius Kabi's access to infusion systems in hospitals, complementing its intravenous fluids and infusion treatment offerings, and reinforcing its position in the US market. Ivenix Inc., a US-based medical technology company, specializes in the development of the Ivenix Large Volume Pump (LVP). This strategic acquisition further strengthens Fresenius Kabi's capabilities in the large volume parenteral market.

Major companies operating in the large volume parenteral (lvp) market report are Pfizer Inc., Fresenius Kabi AG, Abbott Laboratories Inc., Becton Dickinson and Company, Otsuka Holdings Co Ltd., Baxter International Inc., B Braun Melsungen AG, Grifols SA, Cipla Limited, ICU Medical Inc., Biocon Limited, Sichuan Kelun Pharmaceutical Co. Ltd., Alembic Pharmaceuticals Limited, Cadila Healthcare Ltd., Gland Pharma Limited, Akums Drugs & Pharmaceuticals Ltd., Beximco Pharmaceutical Ltd., Nelson Laboratories LLC, Taj Pharmaceuticals Limited, Albert David Ltd., Amanta Healthcare Ltd., Unique Pharmaceutical Laboratories Ltd., Ahlcon Parenterals India Ltd, Parenteral Drugs Limited, Abaris Healthcare Pvt. Ltd., BML Parenteral Drugs, Denis Chem Lab Ltd, Pentagon Labs Ltd., DJ Labs Pvt Ltd., Higgs Healthcare.

North America was the largest region in the large volume parenteral (LVP) market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the large volume parenteral (lvp) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the large volume parenteral (lvp) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The large-volume parenteral (LVP) market consists of sales of sterile intravenous solutions, peritoneal dialysis solutions, plasma substitutes, and sterile powders. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Large Volume Parenteral (LVP) Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on large volume parenteral (lvp) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for large volume parenteral (lvp) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The large volume parenteral (lvp) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Soft Bag LVP; Plastic Bag LVP; Glass Bottle LVP
  • 2) By Volume: 100 ML - 250 ML; 250 ML - 500 ML; 500 ML - 1000 ML; 1000 ML -2000 ML; 2000 And More
  • 3) By Application: Basic Infusion; Therapeutics Infusion; Nutritious Infusion
  • 4) By End-User: Hospital; Medical Centers; Other End Users
  • Companies Mentioned: Pfizer Inc.; Fresenius Kabi AG; Abbott Laboratories Inc.; Becton Dickinson and Company; Otsuka Holdings Co Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Large Volume Parenteral (LVP) Market Characteristics

3. Large Volume Parenteral (LVP) Market Trends And Strategies

4. Large Volume Parenteral (LVP) Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Large Volume Parenteral (LVP) Market Size and Growth

  • 5.1. Global Large Volume Parenteral (LVP) Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Large Volume Parenteral (LVP) Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Large Volume Parenteral (LVP) Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Large Volume Parenteral (LVP) Market Segmentation

  • 6.1. Global Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Soft Bag LVP
  • Plastic Bag LVP
  • Glass Bottle LVP
  • 6.2. Global Large Volume Parenteral (LVP) Market, Segmentation By Volume, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

100 ML - 250 ML

250 ML - 500 ML

500 ML - 1000 ML

1000 ML -2000 ML

2000 And More

  • 6.3. Global Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Basic Infusion
  • Therapeutics Infusion
  • Nutritious Infusion
  • 6.4. Global Large Volume Parenteral (LVP) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital
  • Medical Centers
  • Other End Users

7. Large Volume Parenteral (LVP) Market Regional And Country Analysis

  • 7.1. Global Large Volume Parenteral (LVP) Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Large Volume Parenteral (LVP) Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Large Volume Parenteral (LVP) Market

  • 8.1. Asia-Pacific Large Volume Parenteral (LVP) Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Large Volume Parenteral (LVP) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Large Volume Parenteral (LVP) Market

  • 9.1. China Large Volume Parenteral (LVP) Market Overview
  • 9.2. China Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Large Volume Parenteral (LVP) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Large Volume Parenteral (LVP) Market

  • 10.1. India Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Large Volume Parenteral (LVP) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Large Volume Parenteral (LVP) Market

  • 11.1. Japan Large Volume Parenteral (LVP) Market Overview
  • 11.2. Japan Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Large Volume Parenteral (LVP) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Large Volume Parenteral (LVP) Market

  • 12.1. Australia Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Large Volume Parenteral (LVP) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Large Volume Parenteral (LVP) Market

  • 13.1. Indonesia Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Large Volume Parenteral (LVP) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Large Volume Parenteral (LVP) Market

  • 14.1. South Korea Large Volume Parenteral (LVP) Market Overview
  • 14.2. South Korea Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Large Volume Parenteral (LVP) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Large Volume Parenteral (LVP) Market

  • 15.1. Western Europe Large Volume Parenteral (LVP) Market Overview
  • 15.2. Western Europe Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Large Volume Parenteral (LVP) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Large Volume Parenteral (LVP) Market

  • 16.1. UK Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Large Volume Parenteral (LVP) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Large Volume Parenteral (LVP) Market

  • 17.1. Germany Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Large Volume Parenteral (LVP) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Large Volume Parenteral (LVP) Market

  • 18.1. France Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Large Volume Parenteral (LVP) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Large Volume Parenteral (LVP) Market

  • 19.1. Italy Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Large Volume Parenteral (LVP) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Large Volume Parenteral (LVP) Market

  • 20.1. Spain Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Large Volume Parenteral (LVP) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Large Volume Parenteral (LVP) Market

  • 21.1. Eastern Europe Large Volume Parenteral (LVP) Market Overview
  • 21.2. Eastern Europe Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Large Volume Parenteral (LVP) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Large Volume Parenteral (LVP) Market

  • 22.1. Russia Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Large Volume Parenteral (LVP) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Large Volume Parenteral (LVP) Market

  • 23.1. North America Large Volume Parenteral (LVP) Market Overview
  • 23.2. North America Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Large Volume Parenteral (LVP) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Large Volume Parenteral (LVP) Market

  • 24.1. USA Large Volume Parenteral (LVP) Market Overview
  • 24.2. USA Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Large Volume Parenteral (LVP) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Large Volume Parenteral (LVP) Market

  • 25.1. Canada Large Volume Parenteral (LVP) Market Overview
  • 25.2. Canada Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Large Volume Parenteral (LVP) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Large Volume Parenteral (LVP) Market

  • 26.1. South America Large Volume Parenteral (LVP) Market Overview
  • 26.2. South America Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Large Volume Parenteral (LVP) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Large Volume Parenteral (LVP) Market

  • 27.1. Brazil Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Large Volume Parenteral (LVP) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Large Volume Parenteral (LVP) Market

  • 28.1. Middle East Large Volume Parenteral (LVP) Market Overview
  • 28.2. Middle East Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Large Volume Parenteral (LVP) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Large Volume Parenteral (LVP) Market

  • 29.1. Africa Large Volume Parenteral (LVP) Market Overview
  • 29.2. Africa Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Large Volume Parenteral (LVP) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Large Volume Parenteral (LVP) Market Competitive Landscape And Company Profiles

  • 30.1. Large Volume Parenteral (LVP) Market Competitive Landscape
  • 30.2. Large Volume Parenteral (LVP) Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Fresenius Kabi AG
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Abbott Laboratories Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Becton Dickinson and Company
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Otsuka Holdings Co Ltd.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Large Volume Parenteral (LVP) Market Other Major And Innovative Companies

  • 31.1. Baxter International Inc.
  • 31.2. B Braun Melsungen AG
  • 31.3. Grifols SA
  • 31.4. Cipla Limited
  • 31.5. ICU Medical Inc.
  • 31.6. Biocon Limited
  • 31.7. Sichuan Kelun Pharmaceutical Co. Ltd.
  • 31.8. Alembic Pharmaceuticals Limited
  • 31.9. Cadila Healthcare Ltd.
  • 31.10. Gland Pharma Limited
  • 31.11. Akums Drugs & Pharmaceuticals Ltd.
  • 31.12. Beximco Pharmaceutical Ltd.
  • 31.13. Nelson Laboratories LLC
  • 31.14. Taj Pharmaceuticals Limited
  • 31.15. Albert David Ltd.

32. Global Large Volume Parenteral (LVP) Market Competitive Benchmarking

33. Global Large Volume Parenteral (LVP) Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Large Volume Parenteral (LVP) Market

35. Large Volume Parenteral (LVP) Market Future Outlook and Potential Analysis

  • 35.1 Large Volume Parenteral (LVP) Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Large Volume Parenteral (LVP) Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Large Volume Parenteral (LVP) Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer